Research may provide gluten exposure safety net

02/27/2013 | U.S. News & World Report

Ongoing studies may yield treatments that make gluten less toxic to people with celiac disease or those who are gluten sensitive, says dietitian Tamara Duker Freuman. Researchers are testing larazotide acetate as a way to block a reaction if small amounts of gluten are unintentionally consumed, along with enzyme therapies that could disarm gluten before it harms the digestive system.

View Full Article in:

U.S. News & World Report

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ